216 related items for PubMed ID: 7389739
1. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
von Schnakenburg K, Bidlingmaier F, Knorr D.
Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
[Abstract] [Full Text] [Related]
2. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
Lee PA, Urban MD, Gutai JP, Migeon CJ.
Horm Res; 1980 May; 13(6):347-57. PubMed ID: 7196877
[Abstract] [Full Text] [Related]
3. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[Abstract] [Full Text] [Related]
4. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
[Abstract] [Full Text] [Related]
5. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
6. Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia.
Hatun S, Yordam N, Calikoğlu AS.
Eur J Endocrinol; 1994 Nov; 131(5):504-8. PubMed ID: 7952161
[Abstract] [Full Text] [Related]
7. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM, Mayes DM.
J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
[Abstract] [Full Text] [Related]
8. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
Ghizzoni L, Bernasconi S, Virdis R, Vottero A, Ziveri M, Volta C, Iughetti L, Giovannelli G.
Metabolism; 1994 Mar; 43(3):372-7. PubMed ID: 8139487
[Abstract] [Full Text] [Related]
9. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT, Gourmelen M, Raux-Eurin MC, Girard F.
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[Abstract] [Full Text] [Related]
10. Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Sellers EP, MacGillivray MH.
Endocr Res; 1995 Aug; 21(3):537-44. PubMed ID: 7588424
[Abstract] [Full Text] [Related]
11. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Auer MK, Krumbholz A, Bidlingmaier M, Thieme D, Reisch N.
Neuroendocrinology; 2020 Aug; 110(11-12):938-949. PubMed ID: 31711056
[Abstract] [Full Text] [Related]
12. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[Abstract] [Full Text] [Related]
13. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.
Hughes IA, Winter JS.
J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027
[Abstract] [Full Text] [Related]
14. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M.
Clin Endocrinol (Oxf); 1995 Mar; 42(3):265-72. PubMed ID: 7758231
[Abstract] [Full Text] [Related]
15. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW, Ma HM, Su Z, Du ML, Li YH, Chen HS, Chen QL.
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[Abstract] [Full Text] [Related]
16. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J, Gács G, Keszei K, Láng K, Orley J, Petheö I, Ságodi L.
Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
[Abstract] [Full Text] [Related]
17. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y.
Nihon Naibunpi Gakkai Zasshi; 1991 Aug 20; 67(8):819-39. PubMed ID: 1813324
[Abstract] [Full Text] [Related]
18. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
Sólyom J.
Clin Endocrinol (Oxf); 1981 Jun 20; 14(6):547-53. PubMed ID: 7296904
[Abstract] [Full Text] [Related]
19. The response of pituitary gonadotropes to synthetic LRF in children with glucocorticoid-treated congenital adrenal hyperplasia: lack of effect of intrauterine and neonatal androgen excess.
Reiter EO, Grumbach MM, Kaplan SL, Conte FA.
J Clin Endocrinol Metab; 1975 Feb 20; 40(2):318-25. PubMed ID: 1090842
[Abstract] [Full Text] [Related]
20. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Bréart G, Brauner R, Chalumeau M.
J Clin Endocrinol Metab; 2009 Aug 20; 94(8):2835-40. PubMed ID: 19454583
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
